Summary

The FDA has proposed removing oral phenylephrine, a common ingredient in over-the-counter cold medicines like NyQuil and Sudafed, due to evidence that it is ineffective as a nasal decongestant.

The proposal follows a unanimous vote by FDA advisers last year, and recent studies showing less than 1% of the drug is absorbed into the bloodstream when taken orally.

The public comment period ends on May 7, after which the FDA may finalize the ban.

  • Not_mikey@slrpnk.net
    link
    fedilink
    arrow-up
    0
    ·
    6 days ago

    and Sudafed

    Isn’t Sudafed supposed to be short for pseudoephedrine , the stuff that actually works but they have to keep behind the counter?

    • RandomGen1@lemm.ee
      link
      fedilink
      arrow-up
      0
      ·
      6 days ago

      There’s also Sudsfed PE which is Phenylephrine instead of pseudoephedrine. Presumably only the PE sub-brand would be banned under this rule